Center for Scientific Review; Notice of Closed Meetings, 858-859 [2016-31849]

Download as PDF 858 Federal Register / Vol. 82, No. 2 / Wednesday, January 4, 2017 / Notices TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued Activity Number of respondents Number of responses per respondent Total annual responses Average burden per response Total hours 14,031 total Pilot study completes .............................. 150 (chronic pain) ........ 150 (obesity) 300 (HCP) 1 600 0.33 (20 minutes) ........ 200 1 1,500 0.33 (20 minutes) ........ 500 ........................ ........................ ...................................... 1,355 600 total Main study completes ............................. 375 (chronic pain) ........ 375 (obesity) 750 (HCP) 1,500 total Total ................................................. 1 There ...................................... are no capital costs or operating and maintenance costs associated with this collection of information. mstockstill on DSK3G9T082PROD with NOTICES References The following references are on display in the Division of Dockets Management (see ADDRESSES) and are available for viewing by interested persons between 9 a.m. and 4 p.m., Monday through Friday; they are also available electronically at https:// www.regulations.gov. FDA has verified the Web site addresses, as of the date this document publishes in the Federal Register, but Web sites are subject to change over time. 1. Faerber, A.E. and D.H. Kreling. ‘‘Content Analysis of False and Misleading Claims in Television Advertising for Prescription and Nonprescription Drugs.’’ Journal of General Internal Medicine, 2014. 29(1): 110–118. 2. Symonds, T., C. Hackford, and L. Abraham. ‘‘A Review of FDA Warning Letters and Notices of Violation Issued for Patient-Reported Outcomes Promotional Claims Between 2006 and 2012.’’ Value in Health, 2014. 17: 433– 437. 3. Mitra, A., M.A. Raymond, and C.D. Hopkins. ‘‘Can Consumers Recognize Misleading Advertising Content in a Media Rich Online Environment?’’ Psychology & Marketing, 2008. 25(7): 655–674. 4. Hastak, M., and M.B. Mazis. ‘‘Deception by Implication: A Typology of Truthful but Misleading Advertising and Labeling Claims.’’ Journal of Public Policy & Marketing, 2011. 30(2): 157–167. 5. O’Donoghue, A.C., V. Boudewyns, K.J. Aikin, E. Geisen, et al. ‘‘Awareness of the FDA’s Bad Ad Program and Education Regarding Pharmaceutical Advertising: A National Survey of Prescribers in Ambulatory Care Settings.’’ Journal of Health Communication, 2015. 20: 1330– 1336. 6. Nahin, R.L. ‘‘Estimates of Pain Prevalence and Severity in Adults: United States, 2012.’’ Journal of Pain, 2015. 16(8): 769– 780. 7. U.S. Department of Health and Human VerDate Sep<11>2014 16:46 Jan 03, 2017 Jkt 241001 Services, Centers for Disease Control and Prevention, National Center for Health Statistics (2015). ‘‘Healthy Weight, Overweight, and Obesity Among Adults Aged 20 and Over, By Selected Characteristics: United States, Selected Years 1988–1994 hrough 2009–2012 [Table].’’ In Health, United States, 2014 with special feature on adults aged 55– 64 (pp. 214–220; DHHS Publication No. 2015–1232). Retrieved from http:// www.cdc.gov/nchs/data/hus/hus14.pdf. Dated: December 27, 2016. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2016–31845 Filed 1–3–17; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Biological Chemistry and Macromolecular Biophysics Integrated Review Group; Biochemistry and Biophysics of Membranes Study Section. PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 Date: January 31, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Nuria E. Assa-Munt, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4164, MSC 7806, Bethesda, MD 20892, (301) 451– 1323, assamunu@csr.nih.gov. Name of Committee: Biological Chemistry and Macromolecular Biophysics Integrated Review Group; Synthetic and Biological Chemistry A Study Section. Date: January 31–February 1, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Ritz-Carlton Hotel, 1700 Tysons Boulevard, McLean, VA 22102. Contact Person: Anita Szajek, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4187, Bethesda, MD 20892, 301–827–6276, anita.szajek@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR–14– 264 Global Omics Approaches Targeting Adverse Pregnancy and Neonatal Outcomes Utilizing Existing Cohorts. Date: January 31, 2017. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Lisa Steele, Ph.D., Scientific Review Officer, PSE IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3139, MSC 7770, Bethesda, MD 20892, 301–594– 6594, steeleln@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, E:\FR\FM\04JAN1.SGM 04JAN1 Federal Register / Vol. 82, No. 2 / Wednesday, January 4, 2017 / Notices 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) FOR FURTHER INFORMATION CONTACT: Dated: December 28, 2016. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–31849 Filed 1–3–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY U.S. Citizenship and Immigration Services [CIS No. 2592–16; DHS Docket No. USCIS– 2015–0005] RIN 1615–ZB61 Extension and Redesignation of the Republic of Yemen for Temporary Protected Status U.S. Citizenship and Immigration Services, Department of Homeland Security. ACTION: Notice. AGENCY: Through this Notice, the Department of Homeland Security (DHS) announces that the Secretary of Homeland Security (Secretary) is extending the designation of the Republic of Yemen (Yemen) for Temporary Protected Status (TPS) for 18 months, from March 4, 2017, through September 3, 2018, and redesignating Yemen for TPS for 18 months, effective March 4, 2017, through September 3, 2018. Through this Notice, DHS also sets forth procedures necessary for Yemeni nationals (or aliens having no nationality who last habitually resided in Yemen) either to re-register under the extension, if they already have TPS, and to apply for renewal of their Employment Authorization Documents (EAD) with U.S. Citizenship and Immigration Services (USCIS) or submit an initial registration application under the redesignation and apply for an EAD. DATES: Extension of Designation of Yemen for TPS: The 18-month extension of the TPS designation of Yemen is effective March 4, 2017, and will remain in effect through September 3, 2018. The 60-day re-registration period runs from January 4, 2017 through March 6, 2017. Redesignation of Yemen for TPS: The redesignation of Yemen for TPS is effective March 4, 2017, and will remain in effect through September 3, 2018, a period of 18 months. The 180-day initial registration period for new applicants under the Yemen TPS redesignation runs from January 4, 2017 through July 3, 2017. mstockstill on DSK3G9T082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 16:46 Jan 03, 2017 Jkt 241001 • For further information on TPS, including guidance on the application process and additional information on eligibility, please visit the USCIS TPS Web page at http://www.uscis.gov/tps. • You can find specific information about this extension and redesignation of Yemen for TPS by selecting ‘‘Yemen’’ from the menu on the left side of the TPS Web page. You can also contact Guillermo Roman-Riefkohl, TPS Program Manager, Waivers and Temporary Services Branch, Service Center Operations Directorate, U.S. Citizenship and Immigration Services, Department of Homeland Security, 20 Massachusetts Avenue NW., Washington, DC 20529–2060; or by phone at 202–272–1533 (this is not a toll-free number). Note: The phone number provided here is solely for questions regarding this TPS Notice. It is not for individual case status inquiries. • Applicants seeking information about the status of their individual cases can check Case Status Online, available at the USCIS Web site at http:// www.uscis.gov, or call the USCIS National Customer Service Center at 800–375–5283 (TTY 800–767–1833). • Further information will also be available at local USCIS offices upon publication of this Notice. SUPPLEMENTARY INFORMATION: Table of Abbreviations BIA—Board of Immigration Appeals DHS—Department of Homeland Security DOS—Department of State EAD—Employment Authorization Document FNC—Final Nonconfirmation Government—U.S. Government IJ—Immigration Judge INA—Immigration and Nationality Act OSC—U.S. Department of Justice, Office of Special Counsel for Immigration-Related Unfair Employment Practices SAVE—USCIS Systematic Alien Verification for Entitlements Program Secretary—Secretary of Homeland Security TNC—Tentative Nonconfirmation TPS—Temporary Protected Status TTY—Text Telephone USCIS—U.S. Citizenship and Immigration Services The extension allows TPS beneficiaries to retain TPS through September 3, 2018, so long as they continue to meet the eligibility requirements for TPS. The redesignation of Yemen expands eligibility for TPS to include individuals who have been continuously residing in the United States since January 4, 2017. Previously, only individuals who had been continuously residing in the United States since September 3, 2015, were eligible for TPS under Yemen’s PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 859 designation. The Secretary has determined that an extension of Yemen’s current designation for TPS is warranted because the conditions that supported its designation on the basis of ongoing armed conflict persist. Additionally, the Secretary has determined that a redesignation of Yemen for TPS is warranted due to the ongoing armed conflict and to the extraordinary and temporary conditions in Yemen that prevent Yemeni nationals from returning in safety. The redesignation will extend TPS protection to eligible individuals who have arrived in the United States after the eligibility cutoff dates established by Yemen’s previous designation for TPS in September 2015. The redesignation is based on the Secretary’s determinations under the statute that (1) there continues to be an ongoing armed conflict in Yemen and, due to such conflict, requiring the return of Yemeni nationals to Yemen would pose a serious threat to their personal safety, and (2) there are extraordinary and temporary conditions in Yemen that prevent Yemeni nationals from returning to Yemen in safety, and it is not contrary to the national interest of the United States to permit Yemeni nationals to remain temporarily in the United States. For individuals who have already been granted TPS under Yemen’s designation, the 60-day re-registration period runs from January 4, 2017 through March 6, 2017. USCIS will issue new EADs with a September 3, 2018, expiration date to eligible Yemen TPS beneficiaries who timely re-register and apply for EADs under this extension. Given the timeframes involved with processing TPS reregistration applications, DHS recognizes that not all re-registrants will receive new EADs before their current EADs expire on March 3, 2017. Accordingly, through this Notice, DHS automatically extends the validity of EADs issued under Yemen’s TPS designation for 6 months, through September 3, 2017, and explains how TPS beneficiaries and their employers may determine which EADs are automatically extended and their impact on Employment Eligibility Verification (Form I–9) and E-Verify processes. Under the redesignation, individuals who currently do not have TPS may submit an initial application during the 180-day initial registration period that runs from January 4, 2017 through July 3, 2017. In order to receive a grant of TPS, initial applicants under this redesignation must demonstrate that they have continuously resided in the United States since January 4, 2017 and E:\FR\FM\04JAN1.SGM 04JAN1

Agencies

[Federal Register Volume 82, Number 2 (Wednesday, January 4, 2017)]
[Notices]
[Pages 858-859]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-31849]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Biological Chemistry and Macromolecular 
Biophysics Integrated Review Group; Biochemistry and Biophysics of 
Membranes Study Section.
    Date: January 31, 2017.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Nuria E. Assa-Munt, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4164, MSC 7806, Bethesda, MD 
20892, (301) 451-1323, assamunu@csr.nih.gov.

    Name of Committee: Biological Chemistry and Macromolecular 
Biophysics Integrated Review Group; Synthetic and Biological 
Chemistry A Study Section.
    Date: January 31-February 1, 2017.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel, 1700 Tysons Boulevard, McLean, VA 
22102.
    Contact Person: Anita Szajek, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4187, Bethesda, MD 20892, 301-827-6276, 
anita.szajek@nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-14-264 Global Omics Approaches Targeting Adverse 
Pregnancy and Neonatal Outcomes Utilizing Existing Cohorts.
    Date: January 31, 2017.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Lisa Steele, Ph.D., Scientific Review Officer, 
PSE IRG, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3139, MSC 7770, Bethesda, MD 
20892, 301-594-6594, steeleln@csr.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844,

[[Page 859]]

93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

    Dated: December 28, 2016.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-31849 Filed 1-3-17; 8:45 am]
 BILLING CODE 4140-01-P